Mathieu Peyrou
Impact in
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pneumonia and Respiratory Infections 2
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Alastair E. Cribb (5 shared papers)Paul Hanna (2 shared papers)Shanmugam Muruganandan (1 shared paper)Jérôme M. Giraudel (8 shared papers)Jonathan P. Mochel (7 shared papers)Meindert Danhof (6 shared papers)Martin Fink (6 shared papers)Mark Deurinck (2 shared papers)
- Journals
- Journal of Veterinary Pharmacology and Therapeutics (6 papers)Chronobiology International (2 papers)Toxicological Sciences (2 papers)Pharmaceutical Research (2 papers)Drug Metabolism Reviews (1 paper)
- Partner nations
- SwitzerlandFranceCanada
In The Last Decade
Mathieu Peyrou
22 papers receiving 592 citations
Peers
Comparison fields: 5 of 92
- Cell Biology 139
- Pharmacology 124
- Pharmacology 65
- Equine 10
- Small Animals 39
Countries citing papers authored by Mathieu Peyrou
This map shows the geographic impact of Mathieu Peyrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Peyrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Peyrou more than expected).
Fields of papers citing papers by Mathieu Peyrou
This network shows the impact of papers produced by Mathieu Peyrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Peyrou. The network helps show where Mathieu Peyrou may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Peyrou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 129 | |
| 2 | 2005 | 122 | |
| 3 | 2007 | 63 | |
| 4 | 2014 | 39 | |
| 5 | 2013 | 33 | |
| 6 | 2014 | 24 | |
| 7 | 2010 | 22 | |
| 8 | 2006 | 21 | |
| 9 | 2018 | 20 | |
| 10 | 2004 | 19 | |
| 11 | 2013 | 19 | |
| 12 | 2012 | 19 | |
| 13 | 2013 | 15 | |
| 14 | 2012 | 12 | |
| 15 | 2012 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2007 | 8 | |
| 18 | 2006 | 8 | |
| 19 | 2021 | 7 | |
| 20 | [Evolution of bacterial resistance to certain antibacterial agents in horses in a veterinary hospital]. | 2003 | 6 |
About Mathieu Peyrou
Mathieu Peyrou is a scholar working on Epidemiology, Pharmacology, Cardiology and Cardiovascular Medicine, Clinical Biochemistry and Cell Biology, having authored 23 papers that have together received 607 indexed citations. Recurring topics across this work include Endoplasmic Reticulum Stress and Disease (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Heart Failure Treatment and Management (3 papers), Renin-Angiotensin System Studies (3 papers), Sodium Intake and Health (2 papers), Coccidia and coccidiosis research (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Cell Biology (139 citations), Pharmacology (124 citations), Pharmacology (65 citations), Equine (10 citations) and Small Animals (39 citations). Mathieu Peyrou has collaborated with scholars based in Switzerland, France and Canada. Frequent co-authors include Alastair E. Cribb, Paul Hanna, Shanmugam Muruganandan, Jérôme M. Giraudel, Jonathan P. Mochel, Meindert Danhof, Martin Fink, Mark Deurinck, Alain Bousquet‐mélou and Michèle Doucet. Their work appears in journals such as Journal of Veterinary Pharmacology and Therapeutics, Chronobiology International, Toxicological Sciences, Pharmaceutical Research and Drug Metabolism Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.